{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:58:26Z","timestamp":1791295106096,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intermittent hypoxia (IH), the pathophysiological hallmark of obstructive sleep apnea (OSA), promotes oxidative stress and cardiovascular remodeling. Galectin-3 (Gal-3) is a key mediator of hypoxia-associated inflammatory cardiac injury. ALKBH5, an m6A RNA demethylase detectable in plasma, has not been systematically characterized during hypoxic cardiovascular stress. This experimental study examined plasma ALKBH5 responses to graded IH and evaluated whether pharmacologic Gal-3 inhibition with modified citrus pectin (MCP) modulates circulating ALKBH5 levels and associated cardiac histopathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Male Sprague\u2013Dawley rats (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940) were randomized to five groups (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098\/group): normoxia control; moderate IH (MIH; nadir FiO\n                      <jats:sub>2<\/jats:sub>\n                      10%\u201312%); severe IH (SIH; nadir FiO\n                      <jats:sub>2<\/jats:sub>\n                      5%\u20137%); MIH with MCP (800\u2005mg\/kg\/day); and SIH with MCP. IH exposure was applied for 8\u2005h\/day over 10 days. Endpoint plasma ALKBH5 and Gal-3 concentrations were quantified by ELISA. Cardiac histology was assessed using blinded semi-quantitative injury scoring. Group comparisons were performed using Kruskal\u2013Wallis tests with Dunn's\n                      <jats:italic>post-hoc<\/jats:italic>\n                      correction, and factorial effects were analyzed using aligned rank transform (ART) ANOVA. Correlations were explored using Spearman's rank correlation coefficients due to small sample size and non-normal distributions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Plasma Gal-3 increased in a severity-dependent manner with IH (Control: 18.4\u2009\u00b1\u20093.2; MIH: 34.7\u2009\u00b1\u20095.8; SIH: 48.2\u2009\u00b1\u20097.1\u2005ng\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and was significantly reduced by MCP treatment (36%\u201345% reduction;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01), confirming effective target engagement. Plasma ALKBH5 [median (IQR)] was significantly reduced in SIH compared with controls [691 [562] vs. 2,048 [1,094] pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008], while MIH showed a non-significant trend toward reduction [1,213 (951) pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.089]. MCP treatment was associated with higher plasma ALKBH5 concentrations in both IH groups [MIH\u2009+\u2009MCP: 1,866 [1,698]; SIH\u2009+\u2009MCP: 1,807 [1,595] pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05 vs. respective IH groups]. ART ANOVA demonstrated a significant main effect of Gal-3 inhibition on circulating ALKBH5 independent of hypoxic severity [F(1,28)\u2009=\u200921.28,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001, partial\n                      <jats:italic>\u03b7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.381]. Histological analysis revealed marked myocardial injury in untreated IH groups, whereas MCP-treated animals exhibited markedly attenuated histopathological injury within the limits of semi-quantitative histological assessment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Severe intermittent hypoxia has been linked to a drop in circulating ALKBH5 levels, whereas pharmacological inhibition of galectin-3 has been associated with maintaining plasma ALKBH5 concentrations and a significant reduction of hypoxia-induced myocardial pathological damage in an experimental rat model. These findings suggest circulating ALKBH5 as a hypoxia-responsive molecular signal controlled by inflammatory pathways; however, more mechanistic and longitudinal investigations are necessary to characterize its biological significance and possible translational value.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1805064","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:26:43Z","timestamp":1785997603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma ALKBH5 depletion during severe intermittent hypoxia and its attenuation by galectin-3 inhibition: an experimental rat study"],"prefix":"10.3389","volume":"13","author":[{"given":"Saad","family":"Al-Anazi","sequence":"first","affiliation":[{"name":"Azeer Medical Company","place":["Riyadh, Saudi Arabia"]},{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser A.","family":"Alshawakir","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shahid","family":"Habib","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayam","family":"Gad","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma F.","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanoud","family":"Aljasham","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajd","family":"Althakfi","sequence":"additional","affiliation":[{"name":"Histopathology Unit, Department of Pathology, College of Medicine, King Saud University, King Saud University Medical City","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Mekhtiche","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Al-Masri","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.3390\/ijms24076807","article-title":"Investigating the relationship between obstructive sleep apnoea, inflammation and cardio-metabolic diseases","volume":"24","author":"Alterki","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e22960","DOI":"10.1096\/fj.202201965RR","article-title":"Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea","volume":"37","author":"L\u00f3pez-G\u00e1lvez","year":"2023","journal-title":"FASEB J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.3390\/ijms25105251","article-title":"Sleep apnea and heart failure\u2014current state-of-the-art","volume":"25","author":"Menon","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.18705\/1607-419x-2022-28-4-405-418","article-title":"Atrial fibrillation in patients with obstructive sleep apnea and metabolic syndrome","volume":"28","author":"Ionin","year":"2022","journal-title":"Arterial'naya Gipertenziya"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.15829\/1560-4071-2024-6077","article-title":"Nocturnal hypoxemia, cardiac remodeling, and blood concentrations of fibrosis biomarkers in patients with atrial fibrillation and obstructive sleep apnea","volume":"29","author":"Berdysheva","year":"2024","journal-title":"Russ J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/0003319713483000","article-title":"Serum galectin-3 level predicts the severity of coronary artery disease","volume":"65","author":"Karaka\u015f","year":"2013","journal-title":"Angiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arteri.2024.10.007","article-title":"The mechanisms underlying the cardiac effects of modified citrus pectin in obese rats with myocardial ischemia: role of galectin-3","volume":"36","author":"Jim\u00e9nez-Gonz\u00e1lez","year":"2025","journal-title":"Clin Investig Arterioscler"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2024.2387710","article-title":"Protective effect of galectin-3 inhibitor against cardiac remodelling in an isoprenaline-induced myocardial infarction in type 2 diabetes","volume":"131","author":"Mahmoud","year":"2024","journal-title":"Arch Physiol Biochem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/s41388-023-02704-8","article-title":"M6a methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF-1\u03b1 positive feedback loop","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1002\/CTM2.402","article-title":"Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A","volume":"11","author":"Zhao","year":"2021","journal-title":"Clin Transl Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41556-025-01667-0","article-title":"Psychological stress-induced ALKBH5 deficiency promotes tumour innervation and pancreatic cancer via extracellular vesicle transfer of RNA","volume":"27","author":"Chen","year":"2025","journal-title":"Nat Cell Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbrc.2019.10.145","article-title":"ALKBH5-m6A-FOXM1 Signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia","volume":"521","author":"Chao","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"109929","DOI":"10.1016\/j.clim.2024.109929","article-title":"Hypoxia-induced ALKBH5 aggravates synovial aggression and inflammation in rheumatoid arthritis by regulating the m6A modification of CH25H","volume":"259","author":"Fan","year":"2024","journal-title":"Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1111\/ph.15193","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"177","author":"Du Sert","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1528978","DOI":"10.3389\/fphar.2025.1528978","article-title":"Modified citrus pectin ameliorates methotrexate-induced hepatic and pulmonary toxicity: role of Nrf2, galectin-3\/TLR-4\/NF-\u03baB\/TNF-\u03b1 and TGF-\u03b2 signaling pathways","volume":"16","author":"Ismail","year":"2025","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/pharmaceutics16010073","article-title":"Toxicity studies of cardiac-targeting peptide reveal a robust safety profile","volume":"16","author":"Sahagun","year":"2024","journal-title":"Pharmaceutics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"zsaa293","DOI":"10.1093\/sleep\/zsaa293","article-title":"The effect of chronic intermittent hypoxia in cardiovascular gene expression is modulated by age in a mice model of sleep apnea","volume":"44","author":"Castro-Grattoni","year":"2021","journal-title":"Sleep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/jcm10020277","article-title":"Oxidative stress and inflammation biomarker expression in obstructive sleep apnea patients","volume":"10","author":"Maniaci","year":"2021","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.3390\/ijms22105139","article-title":"Cardiovascular disorders triggered by obstructive sleep apnea\u2014a focus on endothelium and blood components","volume":"22","author":"Mochol","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"106686","DOI":"10.1016\/j.sleep.2025.106686","article-title":"JWA Mediates oxidative stress to promote vascular endothelial repair in obstructive sleep apnea-hypopnea syndrome","volume":"134","author":"Yan","year":"2025","journal-title":"Sleep Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1042\/cs20171389","article-title":"Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage","volume":"132","author":"Ibarrola","year":"2018","journal-title":"Clin Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"110071","DOI":"10.1016\/j.biopha.2020.110071","article-title":"Modified citrus pectin ameliorates myocardial fibrosis and inflammation via suppressing galectin-3 and TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"126","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"B25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/ijms19020379","article-title":"Galectin-3: one molecule for an alphabet of diseases, from A to Z","volume":"19","author":"Sciacchitano","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41401-025-01593-9","article-title":"Circular RNA circDhx32 promotes cardiac inflammatory responses in mouse cardiac ischemia-reperfusion injury via binding to FOXO1 competed with AdipoR1","volume":"46","author":"Si","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B27","doi-asserted-by":"publisher","first-page":"210269","DOI":"10.1183\/16000617.0269-2021","article-title":"Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents","volume":"31","author":"Belaidi","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1093\/cvr\/cvad116","article-title":"Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades","volume":"119","author":"Wang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13046-024-03073-0","article-title":"ALKBH5 Promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages","volume":"43","author":"Hua","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B30","first-page":"431","article-title":"Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets","volume-title":"Sig Transduct Target Ther.","author":"Zhao","year":"2023"},{"key":"B31","first-page":"143","article-title":"The aligned rank transform for nonparametric factorial analyses using only anova procedures","volume-title":"Proceedings of the SIGCHI Conference on Human Factors in Computing Systems (CHI '11)","author":"Jacob","year":"2011"},{"key":"B32","volume-title":"Guide for the Care and Use of Laboratory Animals. 8th ed","year":"2011"}],"updated-by":[{"DOI":"10.3389\/fcvm.2026.1997459","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1805064\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:53:03Z","timestamp":1791291183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1805064\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2026.1805064"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1805064","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1805064"}}